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Summary 
The spinal muscular atrophies (SMAs), characterized 
by spinal cord motor neuron depletion, are among the 
most common autosomal recessive disorders. One 
model of SMA pathogenesis invokes an inappropriate 
persistence of normally occurring motor neuron apop- 
tosis. Consistent with this hypothesis, the novel gene 
for neuronal apoptosis inhibitory protein (NAIP) has 
been mapped to the SMA region of chromosome 
5q13.1 and is homologous with baculoviral apoptosis 
inhibitor proteins. The two first coding exons of this 
gene are deleted in approximately 67% of type I SMA 
chromosomes compared with 2% of non-SMA chro- 
mosomes. Furthermore, RT -PCR analysis reveals in- 
ternally deleted and mutated forms of the NAIP tran- 
script in type I SMA individuals and not in unaffected 
individuals. These findings suggest that mutations in 
the NAIP locus may lead to a failure of a normally oc- 
curring inhibition of motor neuron apoptosis resulting 
in or contributing to the SMA phenotype. 
*The two first authors contributed equally to this work. 
1"Present address: Cyprus Institute of Neurology and Genetics, Nicosia, 
Cyprus. 
Introduction 
The childhood spinal muscular atrophies (SMAs) are a 
group of autosomal recessive neurodegenerative disor- 
ders subclassified as type l (Werdnig-Hoffmann disease), 
type II, and type III (Kugelberg-Welander disease) based 
primarily upon the age of onset of weakness and clinical 
severity (Dubowitz, 1978; Brooke, 1986). There are reports 
of mild pathology throughout he central nervous system 
(CNS), including the anterior columns, thalamus, dorsal 
root ganglia, and lateral geniculate nuclei ('Fowfighi et al., 
1985; Peress et al., 1986; Murayama et al., 1991). How- 
ever, the primary abnormality in SMA is a paucity of the 
(~ motor neurons, manifested as weakness and wasting 
of the voluntary muscles. Type I SMA is the most severe 
form, with onset either in utero or within the first few 
months of life. Affected children are unable to sit unsup- 
ported and rarely survive the first few years owing to respi- 
ratory muscle weakness (Dubowitz, 1978; Brooke, 1986). 
Type I SMA is the most common monogenic cause of 
death in infancy, and, with estimated carrier frequencies 
of 1 in 80 for type I and 1 in 100 for types II and III, the 
SMAs are among the most common autosomal recessive 
disorders (Emery, 1991). 
In 1990 genetic linkage with DNA markers situated in 
the 5q13 region of chromosome 5 was demonstrated for 
all three types of SMA (Brzustowicz et al., 1990; Gilliam 
et al., 1990; Melki et al., 1990). These results suggested 
that different mutations in the same gene or contiguous 
genes account for the three forms of the illness. Since the 
mapping of the SMA locus, a series of recombinations 
defining a progressively smaller critical SMA-containing 
region have been reported (Sheth et al., 1991; Brzustowicz 
et al., 1992; Soares et al., 1993; Wirth et al., 1993, 1994; 
Francis et al., 1993; Burghes et al., 1994a; Clermont et 
al., 1994; Yaraghi et al., submitted). In addition, several 
long-range physical maps based on yeast artificial chro- 
mosome (YAC) contiguous arrays (Kleyn et al., 1993; Fran- 
cis et al., 1993; Wirth et al., 1993; Roy et al., 1995) as 
well as a radiation hybrid analysis (Thompson et al., 1993) 
of the approximately 4 Mb region have been published. 
However, the final step in the search for the SMA gene 
has been confounded by the presence of long-range and 
variable chromosome 5-specific genomic sequence re- 
peats that contain both complex tandem repeat (CTR) poly- 
morphisms as well as amplified transcribed sequences map- 
ping both inside and outside the critical SMA region 
(Francis et al., 1993; Thompson et al., 1993; Roy et al., 
1995; McLean et al., 1994; Burghes et al., 1994b). 
Many of the motor neurons observed at autopsy in SMA 
spinal cords are characterized by swelling and chromatoly- 
sis of cells in a manner that may be consistent with the 
process of programmed cell death or apoptosis. Over the 
past two decades, a central role for apoptosis in the normal 
embryogenesis of the CNS has been delineated (Oppen- 
helm, 1991). As many as 50% of cells in the developing 
eukaryotic CNS, including motor neurons, undergo apop- 
tosis. The motor neuron depletion observed in SMA (Sar- 
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Figure 1. Linkage Disequilibrium and Physical 
Mapping of NAIP Region of 5q13.1 
(A) Correlation of the degree of linkage disequi- 
librium observed in type I SMA families be- 
tween the disease phenotype and six 5q13.1 
markers with the physical map. The SMA- 
containing interval defined by the key recombi- 
nations described in the text is shown. Note 
the proximity of the disequilibrium peak with 
the centromeric end of the recombinant- 
defined SMA interval. 
(B) YAC contiguous array covering the SMA 
region of 5q13.1. For both YAC and PAC con- 
tigs, STSs are denoted by closed triangles, 
polymorphic tandem repeat polymorphisms by
open triangles, and single copy clones by 
closed squares. Note that our physical map 
places the CMS1 sublocus containing allele 9 
telomeric to the other CMS1 subloci, while the 
reverse was observed with genetic recombina- 
tion data, reflecting, we believe, the variation 
that exists in this region of 5q13.1. 
(C) PAC contiguous array covering the SMA 
region of 5q13.1. NAIP gene localization isas 
depicted; the asterisk denotes a deleted ver- 
sion of the NAIP locus. CBCD541 and the highly 
homologous SMN gene found by Lefebvre t 
al. (1995) to be mutated in SMA are also shown. 
Our mapping is at odds with that found by Le- 
febvre t al. (1995), who, as a result of the long- 
range inverted sequence presented in their pa- 
per, place NAIP telomeric to SMN. Although we 
have not observed such a phenomenon, we 
cannot rule this possibility out conclusively. 
(D) Gene structure of NAIP. 
nat, 1983) has led to suggestions that a genetic defect in 
a neuronal apoptotic pathway may result in a pathologic 
persistence or reactivation of normally occurring apopto- 
sis (Sarnat 1983, 1992; Oppenheim, 1991). In support of 
this model, we present a novel gene mapping to the critical 
SMA region of 5q13.1 that we believe when deleted may 
cause or contribute to the SMA phenotype. The neuronal 
apoptotic inhibitory protein (NAIP) contains domains with 
sequence similarity to recently characterized baculovirus 
proteins that inhibit virally induced insect cell apoptosis 
(Clem and Miller, 1993, 1994a, 1994b). 
Results 
Genetic and Linkage Disequilibrium Analyses 
Extensive genotyping with a number of 5q13.1 markers 
has been conducted upon 96 SMA families (MacKenzie 
et al., 1993; McLean et al., 1994; unpublished ata). Many 
of the markers tested are CTR (CA), polymorphisms inso- 
far as they are comprised of several subloci that exist in 
a polymorphic number (0-5) of copies dispersed over the 
critical SMA region of chromosome 5q13.1 (McLean et al., 
1994; Roy et al., 1995). 
We have characterized a recombination event within the 
CMS1 CTR (Kleyn et al., 1993), mapping two of the CMS1 
subloci and the SMA locus distal to the CMS1 sublocus 
containing allele 9 (Yaraghi et al., submitted). This is the 
closest recombination we have detected centromeric to 
the SMA gene. A recombination between the CMS1 CTR 
and SMA has also been observed by van der Steege et 
al. (submitted). The closest telomeric marker recombining 
with SMA in our families was D5S637 (unpublished ata). 
However, a closer telomeric recombination between SMA 
and D5S557 has been previously reported by Francis et 
al. (1993). We estimate the critical 5qcen--CMSl allele 
9 sublocus--SMA--D5S557--5qter interval defined by 
these recombinations to be approximately 550 kb (Figure 
1B; Roy et al., 1995). 
A linkage disequilibrium analysis employing six complex 
and simple tandem repeats mapping to the SMA region 
was also conducted. Two of the polymorphisms employed 
in this analysis were the CATT-40G1 and CATT-192F7 
subloci of the CATT CTR polymorphism (McLean et al., 
1994; Burghes et al., 1994b). A clear linkage disequilib- 
rium peak with the type I SMA phenotype was observed 
for the CATT-40G1 sublocus (McLean et al., 1994; Figure 
1A). Similar disequilibria have been observed for the Agl  
(DiDonato et al., 1994) and C272 (Melki et al., 1994) CTRs. 
Physical Mapping of the SMA Region of 5q13.1 
Concurrent with our genetic analysis, we constructed a 
YAC contiguous array employing clones from three differ- 
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Figure 2. Exon Content of PAC, Fetal Brain cDNA Clones from Non- 
SMA Individuals, and RT-PCR Clones from SMA-Affected Individuals 
E158 refers to the deletion of a glutamate residue. RT-PCR was per- 
formed only between exons 4 and 13; additional undetected deletions 
may exist outside of this region. 
ent YAC libraries (Roy et al., 1995). A minimal representa- 
tion from this array, which was correlated with extensive 
pulsed field gel electrophoresis analysis, is shown in Fig- 
ure lB. 
With the initial suggestion of linkage disequilibrium of 
the general CATT marker and SMA (Burghes et al., 1994b), 
a 220 kb cosmid contiguous array encompassing the five 
CATT subloci contained in a monochromosomally derived 
flow-sorted chromosome 5 genomic library was constructed 
(Roy et al., 1995). More recently, a P1 artificial chromo- 
some (PAC) (Ioannou et al., 1994) contiguous array con- 
taining the CATT region, comprised of nine clones and 
extending approximately 550 kb, was constructed (Fig- 
ure 1C). 
Our genetic analyses, combined with the physical map- 
ping data, indicated that the CATT-40G1 sublocus that 
shows the greatest linkage disequilibrium with SMA is du- 
plicated and maps to the extreme centromeric end of the 
critical SMA interval (Figure 1A). At this point, the 154 kb 
PAC clone 125D9 was discovered to contain within 10 
kb of its centromeric end the allele 9-containing CMS1 
sublocus that defined the centromeric border of the SMA 
interval. The determination that the PAC 125D9 insert ex- 
tended telomerically to incorporate sequence contiguous 
to the CATT-40G1 sublocus as well as roughly one third 
of the SMA interval (Figure 1 C) led to its identification both 
as a probable site of the SMA locus and as a key resource. 
Cloning of the NAIP Gene 
Initial isolation of the NAIP transcript was achieved by 
probing a human fetal brain cDNA library with the 28 kb 
genomic DNA insert of cosmid 250B6 that contains one 
of five CATT subloci present in the cosmid library. This 
resulted in the detection of a 2.2 kb transcript that ulti- 
mately proved to be exon 13 of the NA/P gene. 
Libraries were then constructed from complete and par- 
tial (average insert size, 5 kb) Sau3AI, BamHI, and 
BamHI-Notl digests of PAC 125D9 DNA. Sequencing of 
both termini of 200 clones from the 5 kb insert partial 
Sau3AI digestion library as well as those of BamHI and 
BamHI-Notl clones was conducted in the manner of Chen 
et al. (1993), permitting the construction of contiguous and 
overlapping enomic clones covering most of PAC 125D9 
(data not shown). This has proven instrumental in elucidat- 
ing the gene structure of the NAIP locus. 
PAC 125D9 is divided into 24 kb centromeric and 130 
kb telomeric fragments by Notl digestion that bisects exon 
5 of the NAIP gene (see Figures 3 and 4). These Notl 
fragments were isolated by preparative pulsed field gel 
electrophoresis and used separately to probe human fetal 
brain cDNA libraries. Physical mapping and sequencing 
of the Notl site region were also undertaken to assay for 
the presence of a CpG island, an approach that rapidly 
detected coding sequence. PAC 125D9 was also used as a 
template in an exon-trapping system (Church et al., 1994) 
resulting in the identification of the NA/P gene exons 3, 
10, 14, and 15. 
These approaches resulted in the rapid identification of 
cDNA clones spanning the NAIP locus (Figure 2). Overlap- 
ping clones were identified, and chimerism of cDNA clones 
was excluded on a number of occasions by the detection 
of colinearity of the cDNA clone termini with sequence 
from clones of the PAC 125D9 partial Sau3AI digestion 
genomic library. Sequence analysis revealed the similarity 
between the protein sequence encoded by the NAIP gene 
exons 6-12 and two baculoviral inhibitor of apoptosis pro- 
teins (lAPs) (Birnbaum et al., 1994). Shortly thereafter, 
probing of Southern blots containing DNA from consan- 
guinous SMA families with cDNA probes revealed deleted 
bands. 
NAIP Gene Structure 
A schematic of the NAIP transcript with overlapping cDNA 
clones is shown in Figure 2, and a physical map of the 
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Figure 3. Structure of lntact and InternallyDe- 
leted/Truncated Versions of the NAIP Gene as 
Found in the Indicated PACs 
Exons are marked as numbered closed boxes. 
N refers to the Notl site, B to BamHI sites, and 
E to EcoRI sites. The EcoRV clone that detects 
the 3 kb and 9.4 kb EcoRI bands referred to 
in the text is denoted by EV. The 4.8 kb EcoRI- 
BamHI band deleted in Figure 7 is also de- 
picted. The 6 kb deleted region containing ex- 
ons 5 and 6 and the 23 kb BamHl fragment 
resulting from this deletion are both shown. 
The location of PCR primers is depicted by 
arrows. 
genomic structure of the NAIP locus is depicted in Figure 
3. The NAIP cDNA sequence is shown in Figure 4 and the 
intron/exon splice sequences in Figure 5. The NAIP gene 
contains at least 16 exons comprising a minimum of 5.5 
kb spanning approximately 70 kb of genomic DNA. Intron/ 
exon boundaries were determined both by identification 
of trapped exons and by comparison of cDNA sequence 
with that of clones from the PAC 125D9 clone libraries. 
The initiating NAIP methionine was predicted to be local- 
ized to exon 5, 30 bp downstream of an in-frame stop 
codon. The NAIP gene-coding region spans 3696 nt and 
encodes a 1232 amino acid and 140 kDa protein. The 
nucleic and predicted amino acid sequences of NAIP were 
used in searches of the DNA and protein data bases using 
the BLAST network service (Altschul et al., 1990). No nu- 
cleic acid sequence similarity was detected with any pre- 
viously characterized gene; however, significant amino 
acid sequence similarity was observed with two lAPs, 
CplAP (P = 3e-28; 33% identity over 189 amino acids) 
and OplAP (P = 2.5e-27; 33% identity over 180 amino 
acids) encoded by two baculoviruses, Cydia pomonella 
granulosis virus (Crook et al., 1993) and Orgyia pseudotsu- 
gata nuclear polyhydrosis virus (Birnbaum et al., 1994), 
respectively (Figure 4). 
Both lAPs contain in their N-termini an 80 amino acid 
baculovirus lAP repeat motif that, after an intervening se- 
quence of approximately 30 residues, is duplicated with 
33% identity (Clem and Miller, 1993). The same phenome- 
non is observed in NAIP; amino acids 185-250 encoded 
by exons 5, 6, and 7 are 35% homologous to amino acids 
300-370 encoded in exon 9, 10, and 11. The greatest 
homology is observed over a 53 amino acid region with 
29 identical amino acids. 
In addition to the N-terminal AP domain, there exists 
cysteine- and histidine-rich zinc finger-like motifs in the 
C-terminus of both CplAP and OplAP. These motifs, which 
are proposed to interact with DNA (Birnbaum et al., 1994), 
are not seen in NAIP (Figure 4). 
Searches of protein domain programs generated the 
following results: residues 1-91, an N-terminal domain 
with no recognizable motifs; residues 92-110, a hydropho- 
bic domain predicted by the MEMSAT program (Jones et 
al., 1994) to be a membrane-spanning domain; residues 
163-477, a domain that shows homology with baculoviral 
lAPs followed by (and immediately upstream of the next 
hydrophobic domain of) a GTP/ATP-binding site; residues 
479-496, hydrophobic domain predicted by MEMSAT to 
be a membrane-spanning domain; residues 497-1232, a 
possible receptor domain containing four N-linked glyco- 
sylation sites and a prokaryotic lipid attachment site. We 
know of at least three exons that comprise 400 bp of the 
5' untranslated region (5'UTR); it is possible that more ex- 
ist. A striking feature of this region is the presence of a 
near-perfect duplication of a 90 bp region (Figure 4). In 
addition, the 3'UTR comprising exon 17 has been found 
to contain a 550 bp interval that has potential coding region 
detected by the GRAIL program with high homology (P = 
1.1e-37) to the chicken integral membrane protein oc- 
cludin (Furuse et al., 1993). It is noteworthy that this exon 
is seen only in deleted forms of the NAIP gene (Figure 2); 
thus, the occludin tract does not appear to be a constituent 
of the intact NAIP gene. We also believe it is unlikely to 
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Figure 4. Complete cDNA Sequence and Pre- 
dicted Amino Acid Sequence of NAIP 
Guanine is represented by the lowercase g to 
aid in its distinction from uppercase Cs. Exon 
boundaries are as marked. Arrows underline 
the perfect 90 nt tandem repeat in the 5'UTR 
region. The deleted exons 5 and 6 are stippled. 
The regions of intraprotein repeated amino 
acid homology in the lAP domain are under- 
lined. Sequence comparison with baculoviral 
lAPs is shown; identical residues are darkly 
stippled, and similar residues are lightly stip- 
pled. CplAP and OplAP refer to the lAPs en- 
coded by the baculoviruses Cydia pomonella 
granulosis virus and Orgyia pseudotsugata nu- 
clear polyhydrosis virus, respectively. The se- 
quence comparison has been extended to the 
cysteine/histidine putative DNA-interacting re- 
gion of the baculoviral lAPs; no NAIP homology 
can be seen. The region showing significant 
similarity to chicken occludin, which we have 
found solely in deleted versions of the NAIP 
gene, is shown in the 3'UTR. 
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Figure 5. Intron/Exon Splice Sequences of the NAIP Gene 
Splice junctions of exons of NAIP mapping to PAC 125D9. 
be a chimeric transcript as occludin homologous se- 
quence has been detected in PAC 30B2, which contains 
a deleted version of the NAIP gene. The possibility of the 
occludin sequence representing a coding exon of the NAIP 
gene with the putative 3'UTR actually being heteronuclear 
RNA is also unlikely given the consistency with which the 
3'UTR is observed and the presence of in-frame transla- 
tional stop codons mapping upstream of the region of oc- 
cludin homology. Preliminary reverse transcriptase-poly- 
merase chain reaction (RT-PCR)  analysis indicates that 
the occludin tract is transcribed. 
T issue Expression 
Hybridization of a Northern blot containing adult tissue 
mRNA with an exon 13 probe detected bands only in adult 
liver (approximately 6 and 7 kb bands) and placenta (7 
kb) (Figure 6). Although the level of expression in adult 
CNS is not sufficient to result in visible bands on Northern 
blot analysis, successful RT -PCR amplification of the 
NA/P transcript using spinal cord as well as fibroblast and 
lymphoblast RNA suggests transcriptional activity in these 
tissues. 
Detect ion of Truncated and Internally Deleted 
Vers ions of the NAIP Gene 
PAC analysis by hybridization of Southern blots containing 
PAC DNA with NAIP exon probes and PCR sequence- 
tagged site (STS) content assessment revealed that PAC 
238D12 contained an NAIP locus with exons 1-6 deleted 
and PAC 30B2 contained an NAIP gene with exons 5, 6, 
and 11-14 deleted. The presence of identically sized bands 
in both genomic and PAC DNAs on Southern blot analysis 
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Figure 6. Northern Blot of Adult Tissues Probed with Exon 13 of the 
NAIP Locus 
Tissues are as marked. The filter was washed at 50°C in 0.1 x SSC 
and exposed for 24 hr. Bands can be seen in liver and placenta in 
the 6-7 kb range. 
as well as PCR results outlined below indicated that the 
deletions were real and not cloning artifacts. Probing of 
blots containing BamH I-restricted genomic DNA with NAIP 
exons 2-10 not only reveals a single band comprised of 
equally sized contiguous 14.5 kb BamHI fragments from 
the intact NAIP locus (Figure 3) but also two additional 
bands at 9.6 and 23 kb (Figure 7), fragments that are seen 
in PACs 238D12 and 30B2/25017, respectively. The 9.6 
fragment has been subcloned from a cosmid and found 
to contain exons 7-10, with truncation occurring just up- 
stream of the seventh exon (Figure 3). PCR primers 1882 
and 2050 amplify a 2.6 kb fragment containing the trunca- 
tion site from both PAC 238D12 and genomic DNA. The 23 
kb BamHI band is generated by a 6 kb deletion removing a 
BamHI site leading to the replacement of the two contigu- 
ous 14.5 kb BamHI fragments with a 23 BamHI fragment 
containing exons 1-4 and 7-10 and lacking exons 5 and 
6, as depicted in Figure 3. PCR employing primers 1927 
and 1933, constructed to amplify a 4.2 kb junction frag- 
ment spanning the 6 kb deletion (Figure 3), generated the 
appropriate product as shown by size and sequencing in 
both genomic DNA and PACs 30B2 and 25017. The vari- 
able dosage of both the 9.6 and 23 kb bands seen in geno- 
mic DNA from different individuals indicates that the two 
deleted versions of the NAIP gene are present in multiple 
and polymorphic number in the general population. 
A further level of complexity was detected with the identi- 
fication of clones from a non-SMA human fetal brain cDNA 
library deleted for exons 11 and 12, some of which also 
had exons 15 and 16 absent (Figure 2). The fact that these 
deletions result in frameshifts and premature protein trun- 
cation indicates that they are, rather than normal splicing 
variants, more likely the result of transcription of the de- 
leted and truncated version of NAIP that are present in 
the general population (Figure 3), consistent with amplifi- 
cation of a 1.8 kb fragment missing exons 11 and 12 from 
genomic DNA using primers 1285 and 2048. In all, a profile 
Figure 7. Pedigree and Southern Blot Analysis of Consanguinous 
French-Canadian Type III SMA Families 
(Top) Probing of a filter containing BamHI-EcoRI-digested genomic 
DNA with a cDNA probe encompassing exons 2-9 of NAIP reveals 
the loss of the 4.8 kb fragment that contains exons 5 and6 in all 
affected individuals, resulting i  an in-frame deletion. Allothers, save 
for the homozygously normal sister and brother, show half dosage for 
this band. 
(Bottom) A BamHI digest of the same family. In affected individuals, 
two superimposed 14.5 kb contiguous fragments have sustained the 
6 kb deletion of sequence containing a BamHI site, resulting in the gen- 
eration of a 23 kb band (see Figure 3). Note the existence of the 23 
kb BamHI band in all individuals inthe pedigree in keeping with its 
general dispersion in the population. Similarly, the 9.6 kb BamHI band 
representing the deletion of exons 1-6 that is contained in PAC 238D12 
and depicted in Figure 3 can be seen in all individuals, including non- 
SMA carriers. 
of a region containing a variable number of copies of inter- 
nally deleted and truncated versions of the NAIP locus, 
some of which are transcribed, has emerged from our 
analysis. 
Probings of blots containing DNA from the somatic ell 
hybrid HHW1064 (Gilliam et al., 1989) with NAIP exonic 
probes indicate that all forms of the NAIP gene are con- 
fined to the 30 Mb deleted region of 5ql 1-13.3 contained 
in the derivative chromosome 5 of this cell ine. This finding 
has been confirmed by fluorescence in situ hybridization 
probings with a genomic 2.1 kb BamHI clone containing 
NAIP exons 2 and 3 as well as with PAC 125D9 (unpub- 
lished data). 
NAIP Gene Mutational Analysis 
Probing of genomic Southern blots with PCR-amplified 
NAIP exons 2-9 revealed the absence of a 4.8 kb EcoRI- 
BamHI fragment containing exons 5 and 6 in the four af- 
fected individuals of consanguinous type III SMA family 
24561 (Figures 3 and 7). The same probing of BamHI- 
digested DNA from this family revealed the absence of a 
14.5 kb band, also in keeping with a loss of exons 5 and 
6 as outlined above (Figures 3 and 7). Similar results were 
observed in two other consanguinous French-Canadian 
SMA families. 
To confirm the proposed deletion of exons 5 and 6, we 
made primers homologous to these exons (Figure 3). PCR 
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Figure 8. Results of PCR Amplification in Type Ill Families 21470 and 
24561 Using Primers 1864 and 1863, Which Amplify Exon 5 
The reactions were multiplexed with exon 13 primers 1258 and 1343 
to rule out PCR failure obscuring the results. Failure of amplification 
in keeping with the homozygous absence of exon 5 can be se n to 
cosegregate with the disease phenotype. 
amplification of exon 5 using DNA from family 24561 and 
a second type III SMA consanguinous family revealed co- 
segregation of a failure of amplification with the SMA phe- 
notype (Figure 8). PCR analysis was then extended to 110 
SMA families, employing exon 5 and 6 primers. For these 
exons, 17 of 38 (45°/o) type I SMA individuals and 13 of 72 
(18%) type II and Ill SMA individuals were homozygously 
deleted. Assuming random assortment of chromosomes 
and therefore taking the square root of the observed fre- 
quency of homozygous exon 5 and 6-deleted individuals 
yields estimated frequencies for exon 5 and 6-deleted 
chromosomes of 67% in type I SMA and 42% in type II 
and III SMAs. 
To determine whether the exon 5 and 6 NAIP gene dele- 
tion was an SMA mutation, we conducted Southern blot 
analysis. An 800 bp EcoRV single copy probe that mapped 
immediately 3' to the 6 kb exon 5 and 6 deletion was em- 
ployed (Figure 3). Hybridization of this marker to EcoRI 
Southern blots detected both a 9.4 kb EcoRI fragment 
containing exons 5 and 6 from the intact NAIP locus as 
well as a 3 kb EcoRI band from the exon 5 and 6-deleted 
copy of the NAIP gene. Analysis was conducted on EcoRI 
Southern blots containing DNA from over 900 unrelated 
members of myotonic dystrophy, autosomal dominant 
polycystic kidney disease, and cystic fibrosis families ob- 
tained from our DNA diagnostic laboratory. The 9.4 kb 
band was seen in all individuals in keeping with the pres- 
ence of at least one copy of intact NAIP in each of the 
approximately 900 individuals tested. In addition, the 3 kb 
band was observed in every individual, reflecting a virtu- 
ally complete dispersion of some form of the exon 5 and 
D n n a9 a2a la3a4a8a7 nn G neg 
Figure 9. RT-PCR Amplif ication of RNA on Tissues from SMA and 
Non-SMA Individuals 
The letter n refers to RNA from a non-SMA individual and the letter 
a to RNA from an SMA individual. The tissue source is shown above 
each panel. Lym refers to lymphoblast and fib to fibroblast. All samples 
were from type I SMA patients with the exception of a5, which is from 
an affected member of the consanguinous type III SMA family 24561 
shown in Figure 8. RNA was reverse transcribed from exon 13. Primary 
PCR of products shown i  (A) and (B) was with exon 1 primer 1884 
and exon 13 primer 1285 or 1974 and those in (C) with exon 6 primer 
1919 and exon 13 primer 1285. Secondary PCRs for (A) used exon 
4 primer 1886 and exon 13primer 1974; for (B), exon 5 primer 1864 
and exon 11 primer 1979; and for (C), exon 9 primer 1844 and exon 
13 primer 1974. 
(A) Failure or amplification of reduced products fromspinal cord and 
lymphoblast tissue from individuals a2, a3, a4, a5, a6, and a7. 
(B) Amplification of reduced size bands in a2 and a3; in a7, a larger 
product is shown in keeping with an insertion. 
(C) Reduced band size in keeping with deletions of exons 11 and 12 
in a2, a3, a9, and a11. 
(D) RT-PCR amplification of .~-actin RNA from SMA spinal cord mRNA 
utilizing random hexanucleotides and oligo(dT) primers as described 
in Experimental Procedures. 
6-deleted NAIP gene in the general population. Moreover, 
the variable band dosage observed for the 3 kb band sug- 
gested that the number of copies of the exon 5 and 6-deleted 
NAIP gene is polymorphic, possibly ranging as high as 
four or five copies per genome. 
Next, PCR analysis conducted on 168 parents of SMA 
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children revealed failure of amplification, suggesting ho- 
mozygous deletion of exons 5 and 6 in three individuals. 
This finding was confirmed by Southern blot analysis in 
the two cases with sufficient DNA for this assay. The two 
individuals, aged 28 and 35 and both parents of type I 
SMA children, when interviewed by telephone described 
themselves to be physically well, reporting no symptoms 
suggestive of SMA. It was thus concluded that the deletion 
of NAIP exons 5-6 in isolation, while possibly reflecting 
more extensive deletions in individuals with SMA as out- 
lined below, can be clinically innocuous, associated either 
with an exceedingly mild SMA or even normal phenotype. 
Clinical assessment of these individuals is currently being 
undertaken. 
RT-PCR Amplification of RNA from SMA 
and Non-SMA Tissue 
The results of RT-PCR amplification using RNA from both 
non-SMA and SMA individuals as template are shown in 
Figure 9. We have established that at least some of the 
internally deleted and truncated NAIP versions are tran- 
scribed. To isolate transcripts primarily from the intact 
NAIP gene that would produce a functional protein and 
not those from deleted NA/P, we made an effort to RT- 
PCR amplify transcripts that were as large as possible. 
Given that exon 13 was 2.2 kb, the largest transcript possi- 
ble was found to be one that encompassed exon 2 and 
the 5' end of exon 13. 
A representative subset of RT-PCR experiments is 
shown in Figure 9. PCR amplification of reverse-transcribed 
product using RNA from non-SMA tissues as template and 
reverse transcribing from exons 10 or 13 consistently am- 
plified product of the expected size. In contrast, similar 
RT-PCR experiments on RNA from SMA tissue revealed 
no amplification in five cases in keeping with the marked- 
down regulation or complete absence of the intact tran- 
script in such individuals (Figure 9A). The RNA obtained 
from the SMA tissues was no more than 16 hr postmortem. 
As we had no difficulty in amplifying intact NAIP transcript 
from normal tissue that is 24 hr postmortem, we do not 
believe the difficulty in amplification arises from RNA deg- 
radation. The amplification of I~-actin RNA from the same 
SMA tissues is consistent with this interpretation (Figure 
9D). In the cases in which amplification was observed, 
sequencing of RT-PCR products revealed the following 
findings: in-frame deletion of codons 153-190 from the 3' 
end of exon 5 in sample a9; deletion of exon 6 resulting 
in a frameshift with a stop codon occurring 73 nt into exon 
7 in a product amplified by exon 5 primer 1864 and exon 
8 primer 1843 in sample a2; an approximate 50 nt insertion 
in a product amplified by exon 4 primer 1886 and exon 
13 primer 1974 in sample a7, which is currently being 
sequenced; deletion of glutamic acid codon number 158 
in exon 5 in association with deletion of exons 11 and 12 
in a product amplified by exon 5 primer 1864 and exon 8 
primer 1843 in sample a3; deletion of exons 11 and 12 
introducing a frameshift and a stop codon 14 nt into exon 
13 in a product amplified by exon 9 primer 1844 and exon 
13 primer 1974 in samples a2, a3, a9, and a11. In all, 
employing PCR on material reverse transcribed from exon 
13, we have observed successful amplification of the ap- 
propriate product from all 18 non-SMA tissues attempted 
and in only 3 of 12 SMA tissues. In the latter cases, amplifi- 
cation was from exons 4 to 13 only; whether the transcript 
also incorporates exons 2-3 or 14-17 is unknown. We 
believe that these data are consistent with defects in NAIP 
either resulting in or contributing to the SMA phenotype. 
Discussion 
Relation of the NAIP Gene to SMA 
We present characterization of the gene for a novel pro- 
tein, NAIP. A variable number of copies of intact and par- 
tially deleted forms of the NAIP gene have been found to 
map to 5q 13.1. In contrast with most autosomal recessive 
diseases, in which causal mutations are usually detected 
in the single copy of a given gene, we propose that an 
SMA chromosome is characterized by a paucity or, for 
severe SMA mutations, an absence of the intact NAIP 
gene, possibly resulting from unequal crossing over. 
This model must accommodate the apparently unaffected 
status of the three parents of individuals with SMA who 
do not have a copy of exons 5 and 6 in their genome. 
Judging both by the cDNA clones identified both in normal 
fetal brain libraries as well as the make up of RT-PCR 
NAIP products (Figure 2), many and possibly all truncated/ 
deleted copies of the NAIP gene appear to be transcribed. 
We believe that there is a good possibility that the exon 
5 and 6-deleted version of NAIP is also translated. In keep- 
ing with this model, removal of exons 5 and 6 results in 
an in-frame deletion that extends the longest NAIP open 
reading frame upstream to a start methionine in exon 2 
at nucleotide 211 (Figure 4). Furthermore, the protein se- 
quence encoded by the deleted exon 5-6 lAP motif is 
approximately 35% homologous to the lAP motif encoded 
in exons 10 and 11; the presence of the latter motif may 
account for the absence of discernible phenotype in the 
three exon 5 and 6-deleted individuals. One model is that 
a single copy of exon 5 and 6-deleted NAIP on each chro- 
mosome results in the mild SMA phenotype, while individ- 
uals with greater than three or four copies of the exon 
5 and 6-deleted NAIP locus are clinically unaffected. A 
duplication of the SMA gene underlying the disease has 
recently been proposed by DiDonato et al. (1994). 
The delineation of an SMA genotype in a given individual 
is complicated by the unusual amplification of the NAIP 
gene in the 5q13.1 region. Probings of Southern blots con- 
taining genomic DNA with NAIP exon probes invariably 
reveal bands resulting from copies of internally deleted 
and truncated versions of the NAIP gene. The presence 
of variable numbers of the different forms of the NAIP loci 
in the general population is therefore the norm and not 
diagnostic of an SMA mutation per se, complicating the 
mutational analysis of the NAIP gene. If the detection of 
genomic DNA containing altered NAIP loci affords no proof 
of an SMA chromosome, then, by default, the search must 
be for the absence of the normal NAIP gene. However, 
given the individuals with no copies of exons 5-6 in their 
genome who are clinically unaffected, the identification of 
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an SMA chromosome is contingent on the absence of both 
the intact as well as forms of NAIP in which only exons 
5-6 are deleted. Assaying for their absence is complicated 
by the presence of segments of normal NAIP gene in each 
of the other (more extensively deleted) forms of the NAIP 
locus. We believe that many and perhaps most of the nu- 
merous exon 5 and 6-deleted SMA individuals we have 
observed contain neither the intact NAIP loci nor version 
in which exons 5-6 are deleted, but rather some other 
combination of more extensively truncated/deleted ver- 
sions of the locus with resultant absence of intact NAIP 
translation. Support for this interpretation comes from the 
difficulty encountered in amplifying normal NAIP tran- 
scripts employing RT-PCR on RNA from type I SMA tissue 
and preliminary long-range Southern blot analysis using 
an SMA genomic DNA restricted with rare cutting endonu- 
cleases (unpublished data). 
The presence of a variable number of copies of trun- 
cated and internally deleted versions of the NAIP gene is 
similar to the situation seen with the chromosome 6 CYP21 
gene that encodes steroid 21-hydroxylase (Wedell and 
Luthman, 1993; Collier et al., 1993). CYP21, which when 
mutated causes an autosomal recessive 21-hydroxylase 
deficiency, has been observed in 0-3 copies in different 
individuals. There also exists in the region a variable num- 
ber of inactive pseudogene copies of CYP21 known collec- 
tively as CYP21P. The majority of the CYP21 mutations 
observed in 21-hydroxylase deficiency can also be found 
in some form of CYP21P, and it is thought that the pseu- 
dogenes act as a source of the mutations observed in 
CYP21. The truncated and internally deleted NAIP genes 
might be viewed as analogous to CYP21P and, as has been 
postulated for CYP21/CYP21P, unequal crossing over may 
result in chromosomes deleted for forms of the NAIP gene 
that encode functional protein. We believe that the exis- 
tence of a polymorphic number of mutated NAIP genes 
on 5q13.1 suggests a credible mechanism for generation 
of SMA chromosomes in this fashion. 
In all, the evidence in support of mutations in or the 
absence of the NAIP gene playing a role in the genesis 
of SMA includes the following. First, there is the strong 
possibility that NAIP, given its homology with baculoviral 
lAPs, functions as an inhibitor of apoptosis. This charac- 
teristic is wholly compatible with the pathology of SMA. It 
is noteworthy that mutations in a regulator of apoptosis 
have been previously suggested as a cause of SMA (Op- 
penheim, 1991 ; Sarnat, 1992). Second, there are the map- 
ping of the NAIP locus within the recombination-defined 
critical SMA interval and the fact that polymorphic markers 
have been shown to be in strong linkage disequilibrium 
with type I SMA; C272 (Melki et al., 1994) and Agl (DiDo- 
nato et al., 1994) both map to PAC 125D9 just distal to 
the NAIP locus (Figure 1C). Third, there is the nature of 
linkage disequilibrium observed between the type I SMA 
phenotype and the 5q13.1 markers. We have shown that 
the CATT-40G1 CTR sublocus, which is frequently dupli- 
cated on non-SMA chromosomes (Roy et al., 1995), is 
deleted in 80% of type I SMA chromosomes compared 
with 45% of non-SMA chromosomes (McLean et at., 
1994). This finding is in keeping with a depletion of the 
number of NAIP genes on SMA chromosomes. In a similar 
fashion, Melki et al. (1994) have observed a heterozygote 
deficiency consisting of a reduced number of bands for 
the C272 CTR in type I SMA, reflecting, they propose, 
chromosomal deletions. DiDonato et al. (1994) have also 
seen a striking reduction in the number ofAgl CTR subloci 
in type I SMA individuals when compared with non-SMA 
individuals. We believe that the observation by three 
groups of the depletion of these markers on type I SMA 
chromosomes fits well with the proposed model of a lack 
or absence of both the intact and exon 5 and 6--deleted 
form of the NAIP gene underlying the disease. Fourth, 
there is the markedly increased frequency of NAIP exon 
5-6 deletions observed in SMA chromosomes (approxi- 
mately 67% of type I SMA chromosomes and 42% of type 
II/111 SMA chromosomes) compared with that detected for 
non-SMA chromosomes (2%-3°/0). As outlined above, we 
believe that this phenomenon reflects the rarity or absence 
of both the intact NAIP gene as well as the NAIP version 
with only exons 5-6 deleted in the SMA chromomsomes, 
leaving only the more significantly internally deleted and 
truncated forms of the NAIP gene present. Fifth, there is 
our consistent inability to RT-PCR amplify appropriate 
size transcripts from RNA obtained from 9 of 12 SMA indi- 
viduals despite success with 18 of 18 RNAs from non-SMA 
individuals. Furthermore, sequencing of those RT-PCR 
products that could be obtained from type I SMA material 
revealed a variety of mutations and deletions. 
Baculoviral lAPs 
NAIP shows significant homology with the two baculoviral 
gene products, CplAP and OplAP, that are capable of 
inhibiting insect cell apoptosis. Insect cell apoptosis fol- 
lowing baculoviral infection has been well documented 
and is postulated to be a defense mechanism. Premature 
death of infected insect cells results in an attenuation of 
viral replication (Clem and Miller, 1993, 1994a). CplAP 
and OplAP are thought o represent baculoviral responses 
to this apoptotic mechanism. Both act independently of 
other viral proteins to inhibit host insect cell apoptosis, 
thereby permitting increased viral proliferation (Clem and 
Miller, 1994a, 1994b). They are known to be strongly simi- 
lar only to each other; no sequence similarities with cross 
phyla proteins have been reported. Their mode of action 
is unknown, although some interaction with DNA has been 
postulated. 
Relation of the NAIP Gene to SMN 
Given the comparatively large regions of genomic DNA 
spanned by the various forms of NA/P, it is conceivable 
that neighboring genes from the region might also be in- 
volved with the depletion of NAIP from a chromosome. 
Consistent with this hypothesis, a second gene, called 
SMN (for survival motor neurons), has also been reported 
as being mutated in SMA (Lefebvre et al., 1995 [this issue 
of Ceil]). There are two copies of the gene BCD541, a 
centromeric version called CBCD541 and the telomeric 
TBCD541 or SMN. Mutations in exon 7 and 8 of the telo- 
meric SMN locus, detected by single strand conformation 
polymorphism, are observed in the significant majority of 
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SMA individuals regardless of the severity of the pheno- 
type. It is possible that both the NAIP and SMN proteins are 
involved in the pathogenesis of SMA with SMN mutations 
underlying the majority of SMA mutations and a superim- 
posed NAIP deficiency accounting for the more extensive 
SMA mutations, thereby resolving the absence of appar- 
ent genotype-phenotype correlation seen with SMN mu- 
tations. If both genes are found to be involved in the 
pathogenesis of SMA, the defined and restricted SMA 
phenotype with its underlying cellular specificity suggests 
a mutual interaction of the gene products. One possibilty 
is that NAIP-SMN forms a heterodimer. We have mapped 
the intact NAIP locus into the interval defined by the two 
copies of SMN approximately 60 kb proximal to the telo- 
meric SMN locus (Figure 1). A number of examples of 
contiguous loci encoding distinct subunits for heterodim- 
ers, including murine nerve growth factor (Evans and Rich- 
ards, 1985) and human y-aminobutyric acid receptors (Glatt 
et al., 1994), have been reported. Studies of the gene 
products for such an interaction will be helpful in this 
regard. 
In conclusion, we have identified a region of 5q13.1 that 
contains, in addition to the complete NAIP gene, a variable 
number of copies of internally deleted and truncated forms 
of the gene. We believe that a lack or absence of both 
the intact NAIP gene and the NAIP locus with exons 5 and 
6 deleted from the genome of a given individual is likely 
to cause or (in concert with SMN mutations) contribute to 
the SMA phenotype. Analysis of NAIP at the protein level 
in SMA tissues will be helpful in clarifying its status in the 
pathogenesis of SMA and, possibly, aid in the formulation 
of conventional and genetic therapies for these debilitating 
conditions. Furthermore, the identification of genes show- 
ing homology with the NAIP locus and proteins that interact 
with NAIP may help in the continuing elucidation of apop- 
totic mechanisms in mammalian cells. 
Experimental Procedures 
Family Material 
Clinical diagnoses were conducted as described in MacKenzie et al. 
(1993) with all patients fulfilling the diagnostic criteria given therein. 
DNA was isolated from peripheral leukocytes as described previously 
(MacKenzie et al., 1993). 
Genetic and Linkage Disequilibrium Analyses 
Genotyping with microsatellite markers was as outlined in MacKenzie 
et al. (1993) and McLean et al. (1994). The following 5q13.1 loci were 
used as described: D5S112 (Brzustowicz et al., 1990); D5S351 (Hud- 
son et al., 1992); D5S435 (Soares et al., 1993); D5S557 (Francis et 
al., 1993); D5S629 and D5S637 (Clermont et al., 1994); D5S684 (Brahe 
et al., 1994); Y98T, Y97-r, Y116T, Y122T, and CMS1 (Kleyn et al., 
1993); CATT (Burghes et al., 1994b; McLean et al., 1994); and MAP1B 
(Lien et al., 1991). 
Linkage disequilibrium analyses were conducted using parameters 
that can accommodate the multiple alleles seen with microsatellite 
repeats. Given the complexities inherent in disequilibrium analyses, 
a total of four different parameters for which multiple alleles may be 
used were employed. These were Dij, Dij', and D', as defined in Hedrick 
(1987), and the ~2 test. Two of these, Dij and Dij', have given the best 
a posteriori positional information in a previous study on myotonic 
dystrophy (Podolsky et al., 1994). The patient and control populations 
are as outlined in McLean et al. (1994). 
Cosmid, YAC, and PAC Arraying 
Cosmid and YAC contig assembly was as outlined in Roy et al. (1995). 
PACs were constructed as outlined in Ioannou et al. (1994). Three 
PAC libraries have been constructed using these procedures, with a 
combined total of 175,000 clones, and propagated as individual clones 
in microtiter dishes (P. I. et al., unpublished ata). Pools derived from 
the three libraries (designated LLN L PAC1, RPCI1, and RPCI2) were 
screened with 5q 13.1 STSs. Positive PACs were arranged into contigu- 
ous and overlapping arrays by further analysis with additional STSs 
combined with probings of Southern blots containing PAC DNA by 
single copy genomic DNA and cDNA probes. 
DNA Manipulation and Analysis 
Four genomic libraries containing PAC 125D9 insert were constructed 
by BamHI, BamHI-Notl, and total and partial Sau3AI (selected for 5 
kb insert size) digestions of the PAC genomic DNA insert and sub- 
cloned into Bluescript vector. Sequencing of approximately 400 bp of 
both termini of 200 clones 5 kb in length from the partial Sau3AI diges- 
tion library as well as those of the BamHI and BamHI-EcoRI libraries 
in the manner of Chen et al. (1993) was undertaken. 
Coding sequences from the PACs were isolated by the exon amplifi- 
cation procedure as described by Church et al. (1994). PACs were 
digested with BamHI or with BamHI and Bglll and subcloned into 
pSPL3. Pooled clones of each PAC were transfected into COS1 cells. 
After a 24 hr transfection, total RNA was extracted. Exons were cloned 
into pAMPt 0 (GIBCO BRL) and sequenced utilizing primer SD2 (GTG 
AAC TGC ACT GTG ACA AGC TGC). 
DNA sequencing was conducted on an ABI 373A automated DNA 
sequencer. Two commercial human fetal brain cDNA libraries in Xgt 
(Clontech) and XZAP (Stratagene) were used for candidate transcript 
isolation. The Northern blot was commercially acquired (Ciontech), 
and probing was performed using standard methodology. 
In general, primers used in the paper for PCR were selected for 
Tins of 60°C and can be used with the following conditions: 30 cycles 
of 94°C for 60 s, 60°C for 60 s, and 72°C for 90 s. PCR primer map- 
pings are as referred to in the figure legends and text. Primer se- 
quences are as follows: 1258, ATg CTT ggA TCT CTA gAA Tgg; 1285, 
AgC AAA gAC ATg Tgg Cgg AA; 1343, CCA gCT CCT AgA gAA AgA 
Agg A; 1844, gAA CTA Cgg CTg gAC TCT TTT; 1857, CAT TTg gCA 
TgT TCC TTC CAA g; 1863, CTC TCA gCC TgC TCT TCA gAT; 1864, 
AAA gCC TCT gAC gAg Agg ATC; 1882, CTg AgT CAg ACA CTT 
ACA ggT AA; 1884, CgA CTg CCT gTT CAT CTA CgA; 1886, TTT 
gTT CTC CAg CCA CAT ACT; 1893, gTA gAT gAA TAC TgA TgT TTC 
ATA ATT; 1910, TgC CAC TgC CAg gCA ATC TAA; 1919, TAA ACA 
ggA CAC ggT ACA gTg; 1923, CAT gTT TTA AgT CTC ggT gCT CTg; 
1926, TTA gCC AgA TgT gTT ggC ACA Tg; 1927, gAT TCT ATg TgA 
TAg gCA gCC A; 1933, gCC ACT gCT CCC gAT ggA TTA; 1974, gCT 
CTC AgC TgC TCA TTC AgA T; 1979, ACA AAg TTC ACC ACg gCT 
CTg; 2048, ATg gAg gAg TgT CAT ATA CgC ACT; 2050, TgC TCC 
TCA CTC TTC TAC CIF TTC. 
RT-PCR 
cDNA was synthesized in a 20 p_l reaction utilizing 7 p.g of total RNA. 
The RNA was denatured for 5 min at 95°C and cooled to 37°C. Reverse 
transcription was performed at 42°C for 1 hr after addition of 5 I~1 of 
5x reverse transcription buffer (GIBCO BRL), 2 p.I of 0.1 M DTT, 4 
p.I of 2.5 mM dNTPs, 8 U of RNasin, 25 ng of cDNA primer (1285), 
and 400 U of MMLV (GIBCO BRL). cDNA (1 p.I) was utilized as template 
in subsequent 50 p.I PCRs. Of this primary PCR, 1 p] was utilized as 
template for secondary PCR amplification using nested primers. 
In addition, 11 spinal cord RNA samples (5 p.g of total RNA) were 
reverse transcribed using MMLV reverse transcriptase (GIBCO BRL) 
and random hexamer plus oligo(dT) primers in 20 p.I reactions. PCR 
amplification of 661 bp ~-actin cDNA from 1 i~1 aliquots of reverse 
transcription reactions using Stratagene primers at 65°C annealing 
temperature from these samples was conducted. 
Sequence Analysis 
Primary DNA sequence data were edited with the TED program (Glee- 
son and Hillier, 1991). As many of the partially sequenced 200 clones 
5 kb in length from the partial Sau3AI digestion library as possible 
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were arranged into overlapping arrays using the XBAP Staden pack- 
age (Dear and Staden, 1991). Sequence data were also assembled 
and analyzed using the GCG sequence analysis (University of Wiscon- 
sin Genetics Computer Group). Protein domain homologies were 
found by searching the PROSITE protein data base (Bairoch and 
Bucher, 1994). The MEMSAT program was also used to search for 
transmembrane domain regions (Jones et al., 1994). 
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